Want to see AU:VFX full AI Analyst Report?
Top Page
1st Group Ltd.
(Sydney:VFX)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.05
▼(-46.00% Downside)
Action:Upgraded
Date:08/30/26
The score is primarily constrained by weak financial performance: negative equity, ongoing cash burn, and still-negative operating profitability outweigh the year-over-year reduction in net loss. Technical indicators provide only modest support (positive MACD and RSI in the low 60s), while valuation is not supportive due to a negative P/E and no dividend yield.
Positive Factors
Material reduction in net loss
The sharp reduction in net loss indicates that cost actions or other earnings improvements are having an effect. If sustained, moving toward breakeven could reduce future funding needs and provide a base for operating leverage, although profitability remains unproven.
Negative Factors
Declining revenue and weak top-line momentum
Revenue contraction weakens the company’s ability to absorb fixed costs and limits the potential for operating leverage. Without a durable return to growth, cost reductions alone may not establish a sustainable path to profitability or stronger cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Material reduction in net loss
The sharp reduction in net loss indicates that cost actions or other earnings improvements are having an effect. If sustained, moving toward breakeven could reduce future funding needs and provide a base for operating leverage, although profitability remains unproven.
Read all positive factors
1st Group Ltd. (VFX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$3.90M
Dividend YieldN/A
Average Volume (3M)26.48K
Price to Earnings (P/E)―
Beta (1Y)0.42
Revenue Growth-10.07%
EPS Growth99.60%
CountryAU
Employees10
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding86,643,490
10 Day Avg. Volume10,319
30 Day Avg. Volume26,482
Financial Highlights & Ratios
PEG Ratio0.75
Price to Book (P/B)-296.99
Price to Sales (P/S)1.05
P/FCF Ratio-3.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
1st Group Ltd. Business Overview & Revenue Model
Company Description
Operating in Australia, Visionflex Group Limited and its associated companies specialize in providing cutting-edge healthcare, telehealth, and remote diagnostic services. The company's portfolio features virtual healthcare systems and specialized ...
1st Group Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
9
Very Negative
Cash Flow
12
Very Negative
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.14M | 4.19M | 6.65M | 4.47M | 4.83M |
| Gross Profit | -887.14K | -2.42M | 3.94M | 3.41M | 4.83M |
| EBITDA | -2.06M | -3.37M | -1.32M | -3.56M | -6.43M |
| Net Income | -57.80K | -3.19M | -1.83M | -3.66M | -6.82M |
Balance Sheet | |||||
| Total Assets | 3.09M | 3.39M | 2.88M | 4.09M | 4.27M |
| Cash, Cash Equivalents and Short-Term Investments | 1.62M | 1.89M | 1.16M | 1.44M | 2.01M |
| Total Debt | 577.99K | 2.47M | 13.65M | 12.11M | 4.65M |
| Total Liabilities | 3.11M | 5.22M | 19.76M | 18.73M | 8.16M |
| Stockholders Equity | -14.69K | -1.82M | -8.11M | -6.74M | -3.89M |
Cash Flow | |||||
| Free Cash Flow | -1.27M | -3.19M | -1.38M | -3.68M | -2.82M |
| Operating Cash Flow | -1.26M | -3.16M | 0.00 | 0.00 | 0.00 |
| Investing Cash Flow | -15.56K | -29.51K | 276.80K | 720.13K | -21.84K |
| Financing Cash Flow | 1.02M | 3.92M | 798.81K | 2.36M | 4.59M |
1st Group Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | AU$141.73M | 61.76 | 2.53% | ― | 26.61% | 41.67% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$163.64M | -9.45 | -203.69% | ― | -1.53% | 28.29% | |
50 Neutral | AU$18.60M | ― | -578.72% | ― | 113.42% | 29.17% | |
49 Neutral | AU$35.44M | -1.91 | -58.13% | ― | 2.08% | -195.31% | |
46 Neutral | AU$3.90M | -225.00 | -84.46% | ― | -10.07% | 99.60% | |
43 Neutral | AU$22.99M | -2.53 | -1688.04% | ― | 11.45% | 0.69% |
* Healthcare Sector Average
AU:VFX
1st Group Ltd.
0.05
-0.03
-40.79%
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
0.20
-0.04
-17.02%
AU:BMT
Beamtree Holdings Ltd
0.12
-0.11
-47.83%
AU:ALC
Alcidion Group Limited
0.11
0.02
16.67%
AU:ICR
InteliCare Holdings Limited
0.03
<0.01
52.94%
AU:PCK
PainChek Ltd
0.11
-0.33
-75.00%
1st Group Ltd. Corporate Events
Visionflex files Appendix 4G and updates corporate governance statement
Aug 28, 2026
Visionflex Group Limited has lodged its Appendix 4G and updated Corporate Governance Statement for the financial year ended 30 June 2026, in line with ASX listing rule requirements. The governance statement, approved by the board and made availabl...
Visionflex Narrows Losses and Builds Recurring Revenue Despite FY26 Sales Dip
Aug 28, 2026
Visionflex Group reported FY26 revenue of $4.2 million, down 10% due to customer deferrals of hardware deliveries into FY27, but significantly improved profitability metrics, including an 86% gross margin and an 84% reduction in statutory loss bef...
Visionflex Group Tables 2026 Annual Report for Investors
Aug 28, 2026
Visionflex Group Limited has released its 2026 annual report, which compiles key governance, financial, and operational disclosures for investors. The report includes chair and CEO commentary, detailed directors’ and remuneration reports, pr...
Visionflex slashes annual loss but auditor flags going-concern risks
Aug 28, 2026
Visionflex Group Limited reported a 10% decline in revenue to $4.18 million for the year ended 30 June 2026, but drastically reduced its net loss to $54,772 from $3.09 million a year earlier. The company did not declare dividends and its net tangi...
Visionflex turns cashflow positive and launches unattended virtual care platform
Jul 12, 2026
Visionflex Group Limited reported a cashflow-positive June quarter and second half of FY26, with Q4 operating cash inflow of $0.7m and full-year operating cash outflow reduced to $1.2m, reflecting workforce efficiencies and cost restructuring. Alt...
Visionflex posts positive quarterly cash flow and bolsters liquidity
Jul 12, 2026
Visionflex Group Limited reported quarterly customer receipts of A$2.1 million and positive operating cash flow of A$720,000 for the quarter ended 30 June 2026, marking an improvement on a year-to-date operating cash outflow of A$1.2 million. The ...
Visionflex Wins NSW Health Contract for Statewide Remote Monitoring Hardware
Jun 25, 2026
Visionflex Group Limited has secured an approximately $0.8 million contract with NSW Health to supply proprietary clinical hardware for the state’s Remote Patient Monitoring Digital Uplift program, supporting Virtual Hospital and Hospital in...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.